Pharm-Rx Bacitracin Zinc

Pharm-Rx Bacitracin Zinc contains the active ingredient bacitracin zinc and serves in over-the-counter (OTC) functions within pharmaceuticals and nutraceuticals. Classified as an active pharmaceutical Ingredient (API) under pharmaceutical actives and precursors within pharmaceuticals and nutraceuticals technologies, it's commonly utilized in various pharmaceutical formulations for its therapeutic properties.

Chemical Name: Bacitracin Zinc

CAS Number: 1405-89-6

Chemical Inventories: AICS (Australia), ECL (Korea), EINECS (EU), ENCS (Japan), NDSL (Canada), NZIoC (New Zealand), PICCS (Phillipines), TCSI (Taiwan), TSCA (USA)

Certifications & Compliance: California Proposition 65, FDA 29 CFR 1910.1200

Ask Pharm-Rx Chemical Corp. Questions

Mark Bostel avatar

    Enhanced TDS

    Identification & Functionality

    Chemical Name
    Pharma & Nutraceuticals Functions
    Technologies
    Product Families
    Definition

    Bacitracin Zinc is the zinc complex of bacitracin, which consists of a mixture of antimicrobial polypeptides, the main components being bacitracins A, B1, B2, and B3. It has a potency of not less than 65 Bacitracin Units/mg, calculated on the dried basis. It contains not less than 4.0% and not more than 6.0% of zinc (Zn), calculated on the dried basis.

    Chemical Structure

    Bacitracin Zinc - Chemical Structure

    Applications & Uses

    Properties

    Physical Form

    Regulatory & Compliance

    Certifications & Compliance
    Chemical Inventories
    FDA Disclaimer

    These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

    USP Reference Standards
    • USP Bacitracin Zinc RS

    Packaging & Availability

    Labelling Information

    Label it to indicate that it is to be used in the manufacture of nonparenteral drugs only. Where it is packaged for prescription compounding, label it to indicate that it is not sterile and that the potency cannot be assured for longer than 60 days after opening, and to state the number of Bacitracin Units/mg. Where it is intended for use in preparing sterile dosage forms, the label states that it is sterile or must be subjected to further processing during the preparation of sterile dosage forms.